Skye Bioscience Inc (SKYE)

[Vinpat]

There’s no good reason to do a reverse split at these levels. This could easily run up to a $1 on news and that kind of jump wouldn’t happen if they’re listed on Nasdaq. There probably won’t be much news until the 2nd quarter. EMBI has the IP so they’re more legit than anyone not named GW or Zyne. It all comes down to being able to execute. Murphy is key to advancing this and of course continuing to raise money to get the first trials done which I expect.